iBio European Protein Expression Patent Emerges From Opposition Period
October 27, 2015 08:31 ET
|
iBio, Inc.
NEW YORK, NY--(Marketwired - Oct 27, 2015) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, today announced receipt of...
New Chinese iBioModulator(TM) Patent Joins iBio Vaccine Portfolio
September 30, 2015 08:31 ET
|
iBio, Inc.
NEW YORK, NY--(Marketwired - Sep 30, 2015) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, today announced a notice of...
iBio Anti-Fibrosis Portfolio Expanded to Include Orally Delivered Peptides
September 21, 2015 08:31 ET
|
iBio, Inc.
NEW YORK, NY--(Marketwired - Sep 21, 2015) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biopharmaceutical products, today announced further...
iBio Fibrosis Therapeutics Program Receives NIH Grant Support
September 09, 2015 08:31 ET
|
iBio, Inc.
NEW YORK, NY--(Marketwired - Sep 9, 2015) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biopharmaceutical products, announced the award of a...
iBio to Receive US Patent for Influenza Therapeutic
August 11, 2015 08:31 ET
|
iBio, Inc.
NEW YORK, NY--(Marketwired - Aug 11, 2015) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biopharmaceutical products, received notice that its...
Three Recent iBioLaunch(TM) Platform Achievements to Be Presented at PBVAB 2015 Conference in Lausanne, Switzerland
June 08, 2015 08:31 ET
|
iBio, Inc.
NEW YORK, NY--(Marketwired - Jun 8, 2015) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, announced that three invited...
Vaccine Improvement Patent Awarded to iBio
May 04, 2015 08:31 ET
|
iBio, Inc.
NEW YORK, NY--(Marketwired - May 4, 2015) - iBio, Inc. (NYSE MKT: IBIO) a leader in plant-based biotechnology for developing and manufacturing biological products, today announced the issue of a...
iBio Arranges Production of IBIO-CFB03 for Clinical Development With Caliber Biotherapeutics
April 27, 2015 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Apr 27, 2015) - iBio, Inc. (NYSE MKT: IBIO), has engaged Caliber Biotherapeutics LLC to scale-up and produce materials for clinical development of the first of iBio's...
iBio European Plague Vaccine Patent Emerges From Opposition Period
March 30, 2015 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Mar 30, 2015) - iBio, Inc. (NYSE MKT: IBIO), today announced it received notice from the European Patent Office that the opposition period expired for a bio-defense...
iBio Adds Anthrax Antibodies to Product Pipeline
February 25, 2015 08:31 ET
|
iBio, Inc.
NEWARK, DE--(Marketwired - Feb 25, 2015) - iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, today announced the issue of US...